Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Weiss

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Blood|January 30, 2025
MRD-guided zanubrutinib, venetoclax, and obinutuzumab in relapsed CLL: primary end point analysis from the CLL2-BZAG trialMoritz Fürstenau, Sandra Robrecht, Christof Schneider, et al.
Med (New York, N.Y.)|May 19, 2022
In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin's lymphoma and facilitates ultrasensitive residual disease detectionSophia Sobesky, Laman Mammadova, Melita Cirillo, et al.
Blood|January 22, 2024
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapyJennifer L Crombie, Tara Graff, Lorenzo Falchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancerMartin L Sos, Stefanie Fischer, Roland Ullrich, et al.
Nature Communications|February 22, 2018
Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemiaCarmen D Herling, Nima Abedpour, Jonathan Weiss, et al.
Blood Cancer Journal|November 4, 2022
GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasmsXiangrong Geng, Chenguang Wang, Xin Gao, et al.
The Journal of Clinical Investigation|May 20, 2009
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesionsMartin L Sos, Kathrin Michel, Thomas Zander, et al.
Science Translational Medicine|December 17, 2010
Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancerJonathan Weiss, Martin L Sos, Danila Seidel, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Blood|January 30, 2025
MRD-guided zanubrutinib, venetoclax, and obinutuzumab in relapsed CLL: primary end point analysis from the CLL2-BZAG trialMoritz Fürstenau, Sandra Robrecht, Christof Schneider, et al.
Med (New York, N.Y.)|May 19, 2022
In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin's lymphoma and facilitates ultrasensitive residual disease detectionSophia Sobesky, Laman Mammadova, Melita Cirillo, et al.
Blood|January 22, 2024
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapyJennifer L Crombie, Tara Graff, Lorenzo Falchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancerMartin L Sos, Stefanie Fischer, Roland Ullrich, et al.
Nature Communications|February 22, 2018
Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemiaCarmen D Herling, Nima Abedpour, Jonathan Weiss, et al.
Blood Cancer Journal|November 4, 2022
GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasmsXiangrong Geng, Chenguang Wang, Xin Gao, et al.
The Journal of Clinical Investigation|May 20, 2009
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesionsMartin L Sos, Kathrin Michel, Thomas Zander, et al.
Science Translational Medicine|December 17, 2010
Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancerJonathan Weiss, Martin L Sos, Danila Seidel, et al.
Pageof 14